Frank Gieseler
Impact in
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
-
- Cancer therapeutics and mechanisms 21
- TGF-β signaling in diseases 13
- Extracellular vesicles in disease 8
- Oncology 41
- Pancreatic and Hepatic Oncology Research 12
- Drug Transport and Resistance Mechanisms 9
- Lung Cancer Research Studies 5
- Co-authors
- Hendrik Ungefroren (20 shared papers)Hendrik Lehnert (16 shared papers)Roland Kaufmann (7 shared papers)Utz Settmacher (5 shared papers)Fred Fändrich (5 shared papers)Morley D. Hollenberg (3 shared papers)Dieter Kabelitz (2 shared papers)Daniela Wesch (2 shared papers)
- Journals
- International Journal of Molecular Sciences (5 papers)Leukemia (4 papers)Annals of Hematology (4 papers)PLoS ONE (3 papers)Cell Biology International (3 papers)
- Partner nations
- GermanyUnited StatesCanada
In The Last Decade
Frank Gieseler
96 papers receiving 2.6k citations
Frank Gieseler's Hit Papers
Peers
Comparison fields: 5 of 117
- Oncology 1.1k
- Cancer Research 383
- Hematology 256
- Immunology 353
- Genetics 152
Countries citing papers authored by Frank Gieseler
This map shows the geographic impact of Frank Gieseler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Gieseler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Gieseler more than expected).
Fields of papers citing papers by Frank Gieseler
This network shows the impact of papers produced by Frank Gieseler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Gieseler. The network helps show where Frank Gieseler may publish in the future.
Co-authors
The 25 scholars most cited alongside Frank Gieseler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer Hit paper breakdown → | 2006 | 535 |
| 2 | 2007 | 184 | |
| 3 | 2013 | 148 | |
| 4 | 2002 | 139 | |
| 5 | 2011 | 97 | |
| 6 | 2009 | 82 | |
| 7 | 2004 | 71 | |
| 8 | 2023 | 68 | |
| 9 | 2010 | 44 | |
| 10 | 2013 | 44 | |
| 11 | 2018 | 43 | |
| 12 | 2015 | 43 | |
| 13 | 1999 | 42 | |
| 14 | 2005 | 38 | |
| 15 | P-glycoprotein expression in patients with acute leukemia-clinical relevance. | 1996 | 38 |
| 16 | 2012 | 36 | |
| 17 | 2015 | 36 | |
| 18 | 2013 | 36 | |
| 19 | 2000 | 35 | |
| 20 | 2016 | 34 |
About Frank Gieseler
Frank Gieseler is a scholar working on Molecular Biology, Oncology, Hematology, Cancer Research and Pharmacology, having authored 97 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (21 papers), TGF-β signaling in diseases (13 papers), Pancreatic and Hepatic Oncology Research (12 papers), Drug Transport and Resistance Mechanisms (9 papers), Extracellular vesicles in disease (8 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Lung Cancer Research Studies (5 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (383 citations), Hematology (256 citations), Immunology (353 citations) and Genetics (152 citations). Frank Gieseler has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Hendrik Ungefroren, Hendrik Lehnert, Roland Kaufmann, Utz Settmacher, Fred Fändrich, Morley D. Hollenberg, Dieter Kabelitz, Daniela Wesch, Pierre Rudolph and Udo Kellner. Their work appears in journals such as International Journal of Molecular Sciences, Leukemia, Annals of Hematology, PLoS ONE and Cell Biology International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.